Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.
about
Pre-eclampsia: its pathogenesis and pathophysiolgyThe imbalance in expression of angiogenic and anti-angiogenic factors as candidate predictive biomarker in preeclampsiaA lesson for cancer research: placental microarray gene analysis in preeclampsiaAn unexpected tail of VEGF and PlGF in pre-eclampsiaAssociation of Prenatal Ibuprofen Exposure with Birth Weight and Gestational Age: A Population-Based Sibling StudyExpression of angiogenesis-related genes in the cellular component of the blood of preeclamptic women.Retinoic acid is a cofactor for translational regulation of vascular endothelial growth factor in human endometrial stromal cells.The therapeutic potential of antioxidants, ER chaperones, NO and H2S donors, and statins for treatment of preeclampsia.The change in concentrations of angiogenic and anti-angiogenic factors in maternal plasma between the first and second trimesters in risk assessment for the subsequent development of preeclampsia and small-for-gestational age.Maternal plasma concentrations of angiogenic/antiangiogenic factors in the third trimester of pregnancy to identify the patient at risk for stillbirth at or near term and severe late preeclampsia.Maternal plasma soluble TRAIL is decreased in preeclampsia.First-trimester placental ultrasound and maternal serum markers as predictors of small-for-gestational-age infants.Serum concentrations of soluble Flt-1 are decreased among women with a viable fetus and no symptoms of miscarriage destined for pregnancy loss.Pregnancy-induced hypertension and preeclampsia: levels of angiogenic factors in malaysian womenThe vascular endothelial growth factor family in adverse pregnancy outcomes.Angiotensin II and angiotensin-(1-7) decrease sFlt1 release in normal but not preeclamptic chorionic villi: an in vitro studyUnexplained fetal death is associated with increased concentrations of anti-angiogenic factors in amniotic fluidAn imbalance between angiogenic and anti-angiogenic factors precedes fetal death in a subset of patients: results of a longitudinal study.Gestation dependant changes in angiogenic factors and their associations with fetal growth measures in normotensive pregnancy.Angiogenic and inflammatory biomarkers in midpregnancy and small-for-gestational-age outcomes in Tanzania.Maternal plasma concentrations of sST2 and angiogenic/anti-angiogenic factors in preeclampsia.Circulating angiogenic and antiangiogenic factors in women with eclampsia.Angiogenic factors and preeclampsia.Comparison of placental growth factor and fetal flow Doppler ultrasonography to identify fetal adverse outcomes in women with hypertensive disorders of pregnancy: an observational studyVascular endothelial growth factor and placenta growth factor in intrauterine growth-restricted fetuses and neonates.Evidence in support of a role for anti-angiogenic factors in preterm prelabor rupture of membranes.The Impact of Preeclampsia on Gene Expression at the Maternal-Fetal Interface.Disruption of gap junctions reduces biomarkers of decidualization and angiogenesis and increases inflammatory mediators in human endometrial stromal cell culturesPlacental expression of miR-517a/b and miR-517c contributes to trophoblast dysfunction and preeclampsiaFirst-Trimester Maternal Serum Levels of sFLT1, PGF and ADMA Predict Preeclampsia.Placental lesions associated with maternal underperfusion are more frequent in early-onset than in late-onset preeclampsiaThe Impact of Magnesium Sulfate Therapy on Angiogenic Factors in Preeclampsia.Thrombin regulates soluble fms-like tyrosine kinase-1 (sFlt-1) expression in first trimester decidua: implications for preeclampsiaDeterminants of placental vascularity.Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway.Second trimester anti-angiogenic proteins and preeclampsiaRole of the fetoplacental endothelium in fetal growth restriction with abnormal umbilical artery Doppler velocimetry.Serum and plasma determination of angiogenic and anti-angiogenic factors yield different results: the need for standardization in clinical practice.A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsiaFetal death: a condition with a dissociation in the concentrations of soluble vascular endothelial growth factor receptor-2 between the maternal and fetal compartments.
P2860
Q26746841-F9AD1430-BB71-440C-B6B4-3E1FF02B3319Q26798193-CC9E43CE-5D20-44B5-8BEC-01C3880700C6Q26827543-6BC67E3B-3CA9-4A71-9F21-E03BAFE70B36Q27000996-7E641A9B-41E3-48EE-A310-00B63E90D57FQ28554873-B2C55000-757F-438C-BE4E-C1F20C8624B6Q33454185-045ED0BF-9D66-4DF8-BD50-EC17F95D005DQ33576463-9EEB5048-3C85-4720-B781-09D5B854A401Q33668328-CE386EFC-2F07-4F0A-A276-BB73E493EE06Q33755648-065F9BB7-E370-4F99-8319-1DC79A2098E7Q33863973-80C2D759-8BB0-449F-957E-63C9FD1AA237Q33909572-DDAB2C6A-4D87-4FFB-9E39-A96A477DCAC6Q34111720-7D51CAE3-CA6B-4B6E-BABF-762906E4AE19Q34184588-E47A009C-9CF5-4DFB-AB40-8367B04D4198Q34255236-7D04DA21-1A3D-4FBF-B3AA-7C7A471DC925Q34267491-EB706962-1D43-4DA6-AF07-B37DD8180F92Q34341543-C01DF478-1F17-42D2-8B86-C6D9440355CBQ34470845-95F9B7B9-6891-4CC4-B907-78FFA90BA527Q34505090-9187B520-5E5E-4B92-9527-73D256CBACD5Q34552198-D33B2B84-6EE1-45E7-AFC8-FD155DDB9173Q34587814-DD6A1ACA-A913-44EB-9B92-94A1A04F2A8EQ34619975-0406CC3D-0E3E-4058-81EF-6AE59621725AQ34670638-9C07A95F-EAD3-4FBC-80B9-58B33A2C2ECEQ34714082-42177F62-C26F-42FB-879F-EBE04782DE30Q34929017-AE16C729-473B-452B-B664-F9E518E8C44CQ34945371-CEF1AFC1-CE9A-459E-9844-7882F51E49AFQ35015402-0463690C-5C39-4E91-9E66-48AF2D65B055Q35087258-58E3EF9F-203E-49D1-A755-A1743DD935FAQ35182167-69D04083-7A63-4B70-900C-85BBA9169D5DQ35208938-32669AC2-FEC2-4FFF-876B-CD5C2A4BA6F5Q35532857-4CA96A30-C35B-4503-BF8E-A3C5AEE322A3Q35542826-9229EA46-3F93-4EBB-9E9F-E148DD8702E6Q35661796-9B88FF57-8178-4CC6-B830-E4C4C0D44B95Q35691654-896BB8AE-BC67-419F-AFAD-5AE2CE2E270CQ35814522-1DA06F1E-5917-4647-BD0C-458DD453E62CQ35930861-A3CE18BE-A1AE-4FAB-9743-7817E1A7B4D2Q36034224-5E2F626D-894A-4A9A-BD4B-4CB392F24205Q36118240-A861DB3A-AB7C-45C0-A852-5EBC3AD84AA7Q36185056-EF1359C5-27EB-4D50-9E5E-0D18A7444BE8Q36189562-084DA761-DCF1-49BB-89A2-F7117F6E3234Q36189578-6BE15411-FF39-4E60-8D6E-16182317B3E8
P2860
Longitudinal serum concentrations of placental growth factor: evidence for abnormal placental angiogenesis in pathologic pregnancies.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@en
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@nl
type
label
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@en
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@nl
prefLabel
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@en
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@nl
P2093
P356
P1476
Longitudinal serum concentrati ...... sis in pathologic pregnancies.
@en
P2093
Jane Grimwood
Michael T McMaster
Rennae S Taylor
Robert N Taylor
Robyn A North
Susan J Fisher
P304
P356
10.1067/MOB.2003.111
P407
P577
2003-01-01T00:00:00Z